Entity
Description
  • Value proposition

    3D-living systems to model life

    Research PIECES is a Deeptech Startup of Biotechnology based on the campus of the University of Poitiers, Southwest of France.

    The goals of the startup are to understand the physiology & the physiopathology of the Central Nervous System (CNS) through Research, Development & Treatment.
    For that Research PIECES proposes preclinical biological & innovative models to dissect molecular, cellular and tissular mechanisms in a physiological 3D-living tissue environment.

    One of our main mission is to propose preclinical innovative models to find the future therapeutic molecules against neurological diseases (neurodegenerative diseases, cancer, infectious diseases, etc.).
    Our models are :
    - robust & translatable
    - physiological
    - customized
    - an alternative to animal models

    They can be used :
    - in all the different steps of the early drug discovery (screening, lead of molecules, formulation, test of toxicity, etc.)
    - for pathological models of neurodegenerative diseases (Parkinson, Dementia with Lewy Bodies, Multiple Atrophy System, Alzheimer, etc.), cancer (glioblastome, etc.), etc.
    - to understand the impact of the environment on the CNS with the role of pesticides, endocrine disruptors, etc.
    - For the Army (against neurotoxins)
    - For the Veterinary Industry
    After a 1st achieved R&D phase, our 1st models are now available on the market. More complex models of pathologies are still in R&D and will come soon!

    Because understanding physiopathology, better diagnosis & finding treatments are major challenges for the medicine of tomorrow, there is a real expectation for efficient preclinical robust & translatable models to BETTER approach human physiology/physiopathology & to allow a BETTER environmental risk prevention.

    Research PIECES has the innovation to answer these questions!

    And because together we are stronger, one of the main objectives of the startup is also to raise awareness the general public about Research, Development & Therapeutics.

Catalyst interactions
Catalyst Type Tweets Articles
Innovaud
Innovaud
International Trade and Development (Auto)
Innovaud
International Trade and Development (Auto)
Other

30 Apr 2026


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Roche
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Other

30 Apr 2026


Business France
Business France
National and local authorities, Government Administration (Auto)
Business France
National and local authorities, Government Administration (Auto)
Other

30 Apr 2026


Groupe Roullier
Groupe Roullier
Farming (Auto)
Groupe Roullier
Farming (Auto)
Other

24 Feb 2026


Crédit Agricole de la Touraine et du Poitou Crédit Agricole de la Touraine et du Poitou
Banking (Auto)
Other

26 Nov 2025


ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine
Biotechnology Research (Auto)
Other

29 May 2026


AQUITI Gestion
AQUITI Gestion
Startup accelerator & VC, Financial Services (Auto)
AQUITI Gestion
Startup accelerator & VC, Financial Services (Auto)
Other

31 Jan 2026


Grand Poitiers Communauté Urbaine
Grand Poitiers Communauté Urbaine
Government Administration (Auto), EPCI-50K, French Urban Community
Grand Poitiers Communauté Urbaine
Government Administration (Auto), EPCI-50K, French Urban Community
Other

31 Jan 2026


Le Réseau des Carnot
Le Réseau des Carnot
Research Services (Auto)
Le Réseau des Carnot
Research Services (Auto)
Other

24 Feb 2026


ADI Nouvelle-Aquitaine | Agence de Développement et d’Innovation ADI Nouvelle-Aquitaine | Agence de Développement et d’Innovation
Business Consulting and Services (Auto)
Other

26 Nov 2025


Social network dynamics
Similar entities
BETA
Loading...
Loading...